Radiation therapy, once thought of mainly as a local cancer treatment, is now showing power to awaken the immune system in surprising ways. Researchers discovered that combining radiation with ...

Breakthrough Therapy Designation granted to elironrasib for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer who have received prior ...

Revolution Medicines was granted breakthrough therapy designation for elironrasib, a potential non-small cell lung cancer treatment.

Castle Biosciences' DecisionDx-Melanoma test and Revolution Medicines' elironrasib cancer drug receive FDA Breakthrough ...

A new study has revealed that autoantibodies—immune proteins traditionally associated with autoimmune disease—may profoundly ...

(9926.HK) ("Akeso" or the "Company") is pleased to announce that the first patient has been enrolled in the pivotal/registration Phase III clinical trial (AK112-310/HARMONi-GI2) of ivonescimab, a ...

In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...

A landmark study has revealed that autoantibodies — immune proteins traditionally associated with autoimmune disease — may ...

Researchers saw some cases where a patient’s own autoantibodies boosted likelihood of responding to checkpoint blockade.

The pace of biomedical discovery has never been faster. With mountains of omics data, a flood of new publications, and the pressure to move from hypothesis | Cell And Molecular Biology ...

Payment is part of $17.6 million award granted for leptomeningeal cancer targeted radiotherapeutic development program ...

The global companion diagnostics market is set to surge from USD 7.03 Billion in 2024 to USD 22.83 Billion by 2034, driven by rising cancer prevalenc ...